{"slug":"recruiting","tag":"recruiting","variants":["recruiting"],"description":"No description yet","count":3,"kinds":{"trial":3},"related":[{"slug":"skin","tag":"skin","shared":3},{"slug":"uk","tag":"uk","shared":3},{"slug":"basal-cell-carcinoma","tag":"basal-cell-carcinoma","shared":1},{"slug":"prevention","tag":"prevention","shared":1},{"slug":"radiotherapy","tag":"radiotherapy","shared":1}],"records":[{"id":"impact-bcc","kind":"trial","name":"IMPACT (cemiplimab in advanced basal cell carcinoma)","route":"/trials/impact-bcc/","status":"recruiting","tldr":"The British trial testing whether the immunotherapy that works for advanced squamous cell carcinoma also works, first line, for the advanced basal cell carcinomas NICE refused to fund a hedgehog inhibitor for."},{"id":"spot-it","kind":"trial","name":"SPOT-IT","route":"/trials/spot-it/","status":"recruiting","tldr":"A prevention trial for the group who get these cancers worst: people on long-term immunosuppression, for whom squamous cell carcinoma is not an event but a recurring condition."},{"id":"scc-after","kind":"trial","name":"SCC-AFTER","route":"/trials/scc-after/","status":"recruiting","tldr":"The trial testing a thing the NHS already does without evidence: giving radiotherapy after surgery for a high-risk squamous cell carcinoma, to stop it coming back."}]}